Typ av förfarandeFörhandlat förfarande utan offentliggörande av meddelande om upphandlingFörklaring:
Chalmers hereby announces its intention to sign an agreement with Lablytica Life Science AB, Virdings Alle 16, 754 50 Uppsala, Sweden. VAT 559217-9088 regarding glycosaminoglycan structural and concentration analysis in clinical specimen requiring LC-MS/MS determination in a GCP/GLP-compliant environment due to patient consent from constraints.
A completed market research shows that there is only one supplier that can supply the analysis that meets the requirements of measuring the analytes of interest from a single specimen such that the measurements include both the total concentration of each glycosaminoglycan group as well as the separation and quantification of their disaccharide structural composition both in terms of mass spectrometry-based technology and GLP-level quality for glycosaminoglycan extraction methodology in this field.